New NSF Program Supports Exploratory Research

WASHINGTON—When forest biologist Richard Condit of Princeton University applied for a grant to study how trees in tropical forests are related, the National Science Foundation told him that he had a great idea. But they rejected his application because he couldn’t prove that his approach would work. Condit is trying again, but NSF has decided to give scientists like him a chance to prove their theories without wasting a lot of federal money on experiments that don't work. The ne

Written byElizabeth Pennisi
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—When forest biologist Richard Condit of Princeton University applied for a grant to study how trees in tropical forests are related, the National Science Foundation told him that he had a great idea. But they rejected his application because he couldn’t prove that his approach would work.

Condit is trying again, but NSF has decided to give scientists like him a chance to prove their theories without wasting a lot of federal money on experiments that don't work. The new program is called Small Grants for Exploratory Research (SGER). It provides one-year awards of up to $50,000 through a process that bypasses traditional merit review and lets scientists venture into unexplored—and therefore often unfundable—territory.

“What we really want is for people to try things that they don’t think are ready for a full grant proposal,” says James M. McCullough, director of the NSF program evaluation staff. The program, announced this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies